deltatrials
Recruiting OBSERVATIONAL NCT06286007

Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control (PRIPASCO)

Sponsor: CIBER of Respiratory Diseases CIBERES

Interventions PCR
Updated 9 times since 2024 Last updated: Feb 29, 2024 Started: Dec 21, 2023 Primary completion: Jul 31, 2024 Completion: Jul 1, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06286007, this observational or N/A phase trial focuses on Asthma and Pertussis and remains actively recruiting participants. Sponsored by CIBER of Respiratory Diseases CIBERES, it has been updated 9 times since 2023, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

~Mar 2024 – ~Apr 2024 · 31 days · monthly snapshot~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshotRecruiting~Jan 2025 – ~Mar 2025 · 59 days · monthly snapshot~Mar 2025 – ~Apr 2025 · 31 days · monthly snapshot~Apr 2025 – ~Jun 2025 · 2 months · monthly snapshot~Jun 2025 – ~Sep 2025 · 3 months · monthly snapshotRecruiting~Sep 2025 – present · 10 months · monthly snapshotRecruiting

Change History

9 versions recorded
  1. Sep 2025 — Present [monthly]

    Recruiting

  2. Jun 2025 — Sep 2025 [monthly]

    Recruiting

  3. Apr 2025 — Jun 2025 [monthly]

    Recruiting

  4. Mar 2025 — Apr 2025 [monthly]

    Recruiting

  5. Jan 2025 — Mar 2025 [monthly]

    Recruiting

Show 4 earlier versions
  1. Sep 2024 — Jan 2025 [monthly]

    Recruiting

  2. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  3. Apr 2024 — Jul 2024 [monthly]

    Recruiting

  4. Mar 2024 — Apr 2024 [monthly]

    Recruiting

    First recorded

Dec 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • CIBER of Respiratory Diseases CIBERES
  • Complexo Hospitalario Universitario de A Coruña
  • Consortium for Biomedical Research in Epidemiology and Public Health
  • Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
  • Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
  • Germans Trias i Pujol Hospital
  • Hospital Clinic of Barcelona
  • Hospital Clinico Universitario San Cecilio
  • Hospital Clinico Universitario de Santiago
  • Hospital Costa del Sol
  • Hospital Donostia
  • Hospital El Bierzo
  • Hospital General Universitario Dr. Balmis
  • Hospital Lluis Alcanyís de Xàtiva
  • Hospital San Pedro de Alcantara
  • Hospital Universitario Central de Asturias
  • Hospital Universitario Doctor Peset
  • Hospital Universitario Lucus Augusti
  • Hospital Universitario Marqués de Valdecilla
  • Hospital Universitario Vall d´Hebron
  • Hospital Universitario Virgen de la Arrixaca
  • Hospital Universitario Virgen del Rocio
  • Hospital Universitario de Jerez de la Frontera
  • Hospital Universitario de la Ribera
  • Hospital de Galdakao
  • Hospital de Sagunto
  • Hospital del Mar
  • Hospital of Navarra
  • Translational Research In Airway Diseases Group (TRIAD)
  • Universidade de Santiago de Compostela
  • Universitat Autonoma de Barcelona
  • University Hospital Virgen de las Nieves
Data source: Hospital Clinico Universitario de Santiago

For direct contact, visit the study record on ClinicalTrials.gov .